CHARM Keynote Speakers

We are pleased to welcome the following Keynote Speakers:


Professor Samuel Visken

Professor Sami Visken

Tuesday 31 July, 12-1pm

Director Cardiac Hospitalisation Unit, Tel-Aviv Medical Centre, Israel and Associate Professor Cardiology, Tel-Aviv University, Israel

“History never looks like history when you are living through it.” A comparative history of long QT

The Brugada syndrome (BrS) and long-QT syndrome (LQTS) present as congenital or acquired disorders with diagnostic electrocardiograms (ST-segment elevation and prolonged QT interval, respectively) and increased risk for malignant arrhythmias. Our understanding of the 2 disease forms (congenital vs. acquired) differs. A female patient on quinidine for atrial fibrillation who develops ventricular fibrillation is diagnosed with “acquired LQTS” and is discharged with no therapy other than instructions to avoid QT-prolonging medications. In contrast, an asymptomatic male patient who develops a Brugada electrocardiogram on flecainide is diagnosed with “asymptomatic BrS” and could be referred for anelectrophysiological evaluation that could result in defibrillator implantation. The typical patient undergoing defibrillator implantation for BrS is asymptomatic but has a Brugada electrocardiogram provoked by a drug. The authors describe how the histories of LQTS and BrS went through the same stages, but in different sequences, leading to different conclusions.
View more

Experience in Medical Journals at Senior Level.

  1. Section Editor: Heart Rhythm.
  2. Past Section Editor: Heart Rhythm.
  3. Past Associate Editor: Europace.
  4. Guest Editor: Journal of the American College of Cardiology.
  5. Guest Editor: Heart Rhythm.
  6. Guest Editor: Journal of Cardiovascular Electrophysiology.

Experience in Medical Journals: Editorial Boards and Reviewer Positions.

  1. Editorial Consultant: The Lancet.
  2. Editorial Board: Circulation, Journal of the American College of Cardiology, Heart Rhythm, Journal of Cardiac Electrophysiology, Pacing and Clinical Electrophysiology, Heart (past), Annals of Noninvasive Electrocardiology.
  3. Journal Reviewer: The New England Journal of Medicine, Nature-Clinical Practice, Lancet, Annals of Internal Medicine, Archives of Internal Medicine, Circulation, Circulation-Clinical Electrophysiology, Circulation-Cardiovascular Genetics, Journal of the American College of Cardiology, European Heart Journal, JACC-Clinical Electrophysiology, Europace and 20 other journals.

Awards:

Michel Mirowsky Award in Cardiology in Israel. Israel Heart Society. 2008.

Distinguished Teacher, Tel Aviv University, 2008

Distinguished Physician, Tel Aviv Medical Center, 2009.

Distinguished Reserve Officer, Israel Defence Forces, 2010.

Elite Reviewer Award. Journal of the American College of Cardiology.

Century Reviewer Award. Heart Rhythm.

Simon Dack Award for Outstanding Scholarship from the Journal of the American College of Cardiology, 2013.

Best Publication on the Clinical Studies category in Heart Rhythm, 2014.

Distinguished Cardiologist. Asociación Nacional de Cardiólogos de México, 2014.

Best Presentation, Clinical Catergory. Cardiac Electrophysiology Society, 2014.

Distinguished Scientist Golden Lionel Award, Venice Arrhythmias, Italy 2015

Task Force Member:

  1. American Heart Association, Position Paper. Analysis of the 12-lead ECG as a Screening Test for Detection of Cardiovascular Disease in General Populations of Young Healthy People (ages 12-22 years). 2014.
  2. European Society of Cardiology, Position Paper. Management of patients with palpitations: Position paper from the European Heart Rhythm Association. 2014.
  3. American Heart Association Committee on Electrocardiographic Early Repolarization. Member of the writing committee, 2014.
  4. American Heart Association, American College of Cardiology and European Society of Cardiology GUIDELINES on Ventricular Arrhythmias and Sudden Cardiac Death. Reviewer.

Publications:

206 publications in peer reviewed journals, first or last author in >95%.

 


Professor Sir Harry Burns

Professor Sir Harry Burns

Wednesday 1 August, 12-1pm

Professor of Global Public Health, University of Strathclyde, Institute of Global Public Health and International Prevention Research Institute Glasgow, Scotland

Population determinants of health and wellbeing

Sir Harry’s principal interest is in using Improvement Science to transform the lives of people, particularly children and young people living socially difficult lives. Sir Harry uses evidence to support his argument that adversity in early years can have considerable, biological consequences in later life.

More widely, his focus is on how societies can create “wellness” – where health is a state of complete physical, mental and social wellbeing, not merely the absence of illness. By looking at the association of social patterns and health, it is possible to develop interventions which are aimed at narrowing health inequalities and enabling individuals to find meaning and have a sense of coherence in their lives.

To be effective, this requires collaboration across health, education, social services, academia and government. Sir Harry’s work reflects this range and scope.
View more

Sir Harry Burns graduated in medicine from Glasgow University in 1974. He trained in surgery in Glasgow and was appointed as a Consultant Surgeon in the University Department of Surgery at the Royal Infirmary in Glasgow in 1984. Working with patients in the east end of Glasgow gave him an insight into the complex inter-relationships between social and economic status and illness. He completed a Master’s Degree in Public Health in 1990 and shortly afterwards was appointed Medical Director of The Royal Infirmary.

In 1994, he became Director of Public Health for Greater Glasgow Health Board, a position he occupied until 2005. During his time with Greater Glasgow Health Board, he continued research into the problems of social determinants of health and in 2005, he became Chief Medical Officer for Scotland. In this role, his responsibilities included aspects of public health policy, health protection and, for a time, sport.

He was knighted in 2011. In April 2014 he became Professor of Global Public Health at Strathclyde University where he continues his interest in understanding how societies create wellness. In addition to his University work, Sir Harry is Chair of the Wheatley Foundation, the charitable trust of the Wheatley Group which supports people in the Wheatley community who may be disadvantaged or vulnerable; he is a Board member of Diabetes UK and of Spirit of 2012, the London 2012 legacy charity, a Trustee of the STV Children’s Appeal Board and a Governor of St Aloysius College.

In 2014, the First Minister, Nicola Sturgeon, presented him a lifetime achievement award from the Scottish Government and the Scottish Parliament for Public Service. In September 2016, the Scottish Government announced that he would chair an independent review of targets in Scotland's NHS. The Report was published in November 2017.

 


Professor Maree Teesson

Professor Maree Teesson

Thursday 2 August, 12-1pm

Professor, Director National Health and Medical Research Council (NHMRC), Centre of Research Excellence in Mental Health and Substance Use (CREMS) and NHMRC Principal Research Fellow at the National Drug and Alcohol Research Centre (NDARC), Professorial Fellow at the Black Dog Institute, UNSW Sydney.

Pathways to prevention: The long-term effectiveness of prevention and early intervention for substance use and related harms

Young Australian adulthood is characterised by increased use of alcohol and cannabis, and heightened risk of harms associated with this use including injury, self-harm or violent behaviour, and onset of alcohol or drug use disorders. This high prevalence of use is of particular concern given earlier initiation of use is a risk factor for poorer health outcomes, all of which negatively impact on current functioning, health and future life options. Ideally, preventive interventions should delay onset of alcohol and other drug use in low-risk adolescents who may be influenced by peer factors or social conformity, and high-risk adolescents whose underlying vulnerability may lead to alcohol and drug misuse.
View more

Professor Maree Teesson AC, is the Director of the NHMRC Centre of Research Excellence in Mental Health and Substance Use (CREMS), an NHMRC Principal Research Fellow at the National Drug and Alcohol Research Centre (NDARC), and a Professorial Fellow at the Black Dog Institute, UNSW Sydney. She is also a Fellow of the Australian Academy of Health and Medical Sciences and Fellow Australian Academy of Social Sciences.

Maree’s vision is to build the world’s leading dedicated translational research program for the prevention and treatment of mental disorders and substance abuse. She seeks to increase our understanding of drug and alcohol and mental disorders, prevent these where possible and improve treatment responses. She is known internationally for her innovative use of technology to implement large scale prevention with adolescents.

Maree has made a substantial contribution to medical research with over 280 research articles, reviews, book chapters and books. The innovation of her research has been recognised through leadership of over 100 grants totalling over $47M.

Maree’s awards include the prestigious Australian Museum Eureka Prize for Mentoring Young Researchers; Senior Scientist Award by the Australian Professional Society on Alcohol and Drugs; SMHR Oration Award; SMHR Founders Medal; and Westpac/Australian Financial Review 100 Women of Influence (Innovation).